Washington, D.C. 20549  


Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 17, 2020

(Exact name of registrant as specified in its charter)  
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
540 Gaither Road, Suite 400, Rockville, Maryland 20850
(Address of principal executive offices) (Zip Code)
Registrant’s Telephone Number, Including Area Code: (410) 522-8707

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 Par Value
Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ý

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ý

Item 1.01.     Entry into a Material Definitive Agreement.

Securities Purchase Agreement

On March 17, 2020, Cerecor Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with funds associated with Armistice Capital, LLC (the “Buyer”), a significant stockholder of the Company, pursuant to which the Company sold 1,951,219 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) for a purchase price of $2.05 per share, which was the closing price of shares of the Common Stock on March 17, 2020. Gross proceeds of the Securities Purchase Agreement total approximately $4,000,000.

The Securities Purchase Agreement contains customary representations and warranties of the Company and the Buyers.

The Company intends to use the net proceeds of the offerings, which are approximately $3,900,000, for general corporate purposes.
The Shares issued were sold in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on Section 4(a)(2) thereof. The Shares may not be offered or sold in the United States absent registration or exemption from registration under the Securities Act and any applicable state securities laws.

Registration Rights Agreement

In connection with the Securities Purchase Agreement, the Company entered into a Registration Rights Agreement with the Buyer, dated March 17, 2020 (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Company has agreed to file a registration statement registering for resale the shares of common stock sold in the private placement. The Company has agreed to file such registration statement within 60 days of the Closing Date (as defined in the Securities Purchase Agreement).

The foregoing descriptions of the Securities Purchase Agreement and the Registration Rights Agreement are not complete and are qualified in their entirety by reference to the full text of the Securities Purchase Agreement and the Registration Rights Agreement, which are attached hereto as Exhibit 10.1 and 10.2, and are incorporated herein by reference.
The information contained in this Current Report on Form 8-K is not an offer to sell or the solicitation of an offer to buy shares of our Common Stock or any other securities of the Company.

Item 3.02.     Unregistered Sales of Equity Securities.

The information contained in Item 1.01 is incorporated herein by reference.

 Item 9.01.     Financial Statements and Exhibits.

(d)    Exhibits.    

Exhibit No.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 18, 2020
/s/ Joseph M. Miller
Joseph M. Miller
Chief Financial Officer